Franklin Resources’s SpyGlass Pharma SGP Stock Holding History

Franklin Resources’s Portfolio SGP Stock Details SGP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.04M	Hold	233,412	–	–	﹤0.01%	1373
2026 Q2	$5.2M	Sell	233,412 -66,588	-22%	-$1.44M	﹤0.01%	1584
2026 Q1	$7.77M	Buy	+300,000	New	+$8.07M	﹤0.01%	1335

Other funds holding SGP

Sands Capital Ventures Arlington, Virginia $695M AUM 31.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

Franklin Resources's SGP Position: Q3 2026 in Review

Franklin Resources held its SpyGlass Pharma (SGP) position steady in Q3 2026 at 233,412 shares worth $8.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

Franklin Resources first reported a position in SGP in Q1 2026 and has held it in 3 quarters since. 47 funds tracked by Wall St. Rank hold SGP as of Q3 2026.

Franklin Resources held 233,412 shares of SpyGlass Pharma worth $8.04M as of Q3 2026.
Franklin Resources left its SpyGlass Pharma share count unchanged in Q3 2026.
SpyGlass Pharma made up ﹤0.01% of Franklin Resources's portfolio in Q3 2026, its #1373 holding.
Franklin Resources first reported a position in SpyGlass Pharma in Q1 2026 and has held it in 3 quarters since.
47 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q3 2026.

Based on Franklin Resources's 13F filing for Q3 2026, filed 12 Nov 2026.